Saturday January 16, 2021
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International West
    • |COVID-19 Therapeutic Development & Production
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

Manufacturing

Compliance Issues for Innovator and Generic Biopharmaceuticals

by BPI Contributor
Add Comment
November 1, 2004

Disposable Assemblies in Biopharmaceutical Production

by BPI Contributor
Add Comment
October 1, 2004

Considerations for Use of Disposable Technology in Contract Manufacturing

by BPI Contributor
Add Comment
October 1, 2004

Biomanufacturing for the 21st Century

by BPI Contributor
Add Comment
October 1, 2004

DSA-FACE

by BPI Contributor
Add Comment
September 1, 2004

Would Your Company Survive Disaster?

by BPI Contributor
Add Comment
September 1, 2004

Navigating FDA Regulations for Human Cells and Tissues

by BPI Contributor
Add Comment
September 1, 2004

European Comparability Guidances Acknowledge Follow-On Manufacturers

by BPI Contributor
Add Comment
September 1, 2004

How the Data Ecosystem Affects Process Development and the Bottom Line

by BPI Contributor
Add Comment
May 1, 2004

Integrating Emerging Technologies To Create a New Multiproduct Facility Design

by BPI Contributor
Add Comment
May 1, 2004
  • <
  • 1
  • ...
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • ...
  • 93
  • >

Editor’s Choice

  • BioProcess Insider

    Fujifilm $2bn US expansion plan to triple global mammalian capacity

  • BioProcess Insider

    Up on the downstream: Sartorius to buy Novasep’s chromatography division

  • Sponsored Content

    The next frontier of CAR-T cell therapies: Allogeneic workflows

  • BioProcess Insider

    COVID-19 has spurred long-lasting innovation, says expert

  • BioProcess Insider

    SK Holdings set to jump into cell and gene CDMO space with Yposkesi buy

  • Sponsored Content

    Reducing Risk in Bioproduction with Facilities Equivalency

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar @thermofisher adds EU viral vector plants in €725m @Novasep deal: TF Boosts #CDMO gene therpay biz, while Novasep d… https://t.co/iHylkRjibs 14 hours ago
  • Tweet Avatar RT @Dan5tanton: Moderna says it has capacity to deliver 1 billion doses of its mRNA COVID-19 vaccine but with raw materials in high… https://t.co/5e5BAjWjUN 2 days ago
  • Tweet Avatar RT @Dan5tanton: CureVac has hired Bayer to help develop mRNA-based medicines including the COVID-19 vaccine candidate, CVnCoV. Baye… https://t.co/vqwFjo1Kmx 1 week ago
  • Tweet Avatar RT @Dan5tanton: Up on the downstream: Sartorius Stedim Biotech says it continues to take on the challenges in efficient downstream… https://t.co/qsAJVTPzZW 1 week ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    WuXi to make COVID-19 vaccine at shelved Bayer hemophilia drug plant

  • BioProcess Insider

    BMS cites Lonza plant inspection as factor in liso-cel’s ongoing delay

  • BioProcess Insider

    Up on the downstream: Sartorius to buy Novasep’s chromatography division

  • BioProcess Insider

    Plan to make 1.3bn vaccines in 2021 places strain on Pfizer’s production network

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2021 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International West
    • COVID-19 Therapeutic Development & Production
  • BioProcess International Academy
  • Events